NeoGenomics Inc (NEO)

NeoGenomics Inc (NEO) is a Diagnostics & Research company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $2.1B; returns 1 day +1.2%, 1 week -0.4%, 1 year +58.8%.

NeoGenomics Inc. (NEO) is a cancer diagnostics company specializing in cancer genetics testing and information services. They provide a comprehensive oncology-focused testing menu, serving pathologists, oncologists, academic centers, hospital systems, pharmaceutical firms, and managed care organizations throughout the United States and Europe.

Groups NEO belongs to

• Healthcare
• Oncology
• Health Diagnostics and Imaging
• Cancer Therapeutics
• Biotechnology
• Life Sciences Tools & Services
• Clinical Stage
• Healthcare Services
• Pharmaceuticals
• Early Cancer Detection

NEO financial model: income statement, cash flow and balance sheet